Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Sholl · SciRah

Researcher profile · Semantic Scholar

L. Sholl

Share profile

L. Sholl — researcher profile on SciRah

h-index: 96
Works: 624
Citations: 36K

Most-cited papers

Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non-Small Cell Lung Cancer.
B. Ricciuti, Francesca Fusco, Alissa J. Cooper, E. Garbo +24 more
2025JAMA Oncology42 citations Open access
Semantic Scholar
Updated pan-tumor guidelines for neoadjuvant scoring of pathologic response: a joint SITC and INMC effort
J. S. Deutsch, R. Scolyer, E. Burton, K. Busam +19 more
2025Annals of Oncology21 citations
Semantic Scholar
Gene copy deletion of STK11, KEAP1, and SMARCA4: clinicopathologic features and association with outcomes to immunotherapy +/- chemotherapy in nonsquamous non-small cell lung cancer.
Malini M. Gandhi, A. Elkrief, Catherine Gutierrez Moore, B. Ricciuti +13 more
2025Journal of Thoracic Oncology20 citations
Semantic Scholar
Assessment and classification of sex cord‐stromal tumours of the testis: recommendations from the testicular sex cord‐stromal tumour (TESST) group, an Expert Panel of the Genitourinary Pathology Society (GUPS) and International Society of Urological Pathology (ISUP)
A. Acosta, M. Colecchia, Eva Compérat, Kristine Cornejo +18 more
2025Histopathology17 citations Open access
Semantic Scholar
Standardized Clinical Terms and Definitions for Interstitial Lung Disease: A Consensus Statement from the Fleischner Society.
C. Ryerson, A. Bankier, M. B. Beasley, Kevin K. Brown +26 more
2025American Journal of Respiratory and Critical Care Medicine16 citations
Semantic Scholar
Molecular Tumor Boards: A consensus statement from the International Association for the Study of Lung Cancer.
M. Aldea, J. Rotow, M. Arcila, M. Hatton +36 more
2025Journal of Thoracic Oncology15 citations Open access
Semantic Scholar
Pan-cancer spatial characterization of key immune biomarkers in the tumor microenvironment
James R. Lindsay, J. Altreuter, J. Alessi, J. Weirather +13 more
2025bioRxiv13 citations Open access
Semantic Scholar
MET (c-Met) protein overexpression is an emerging protein biomarker in non-small cell lung cancer
M. Tsao, L. Sholl, Michelle Shiller, Peter Illei +7 more
2025npj Precision Oncology12 citations Open access
Semantic Scholar
Contrastive learning enhances fairness in pathology artificial intelligence systems
Shih-Yen Lin, Pei-Chen Tsai, Fang-Yi Su, Chun-Yen Chen +25 more
2025Cell Reports Medicine12 citations
Semantic Scholar
MA04.02 Nautika1: Clinical Outcomes and Pathologic Regression With Neoadjuvant Alectinib in Resectable Stage IB-IIIB ALK + NSCLC
J. Lee, M. Negrao, A. Cummings, E. Shum +15 more
2025Journal of Thoracic Oncology10 citations Open access
Semantic Scholar
Uncovering the role of LINE-1 in the evolution of lung adenocarcinoma
Tong-Wu Zhang, Wei Zhao, C. Wirth, M. Díaz-Gay +64 more
2025Nature10 citations Open access
Semantic Scholar
Molecular characterization of NUT carcinoma: a report from the NUT carcinoma registry
Justin J. Kim, S. A. Walton, N. Mahadevan, J. Haradon +13 more
2025Clinical Cancer Research9 citations
Semantic Scholar
DNA methyltransferase 3A (DNMT3A) mutations and PD-(L)1 blockade efficacy in non-small-cell lung cancer
B. Ricciuti, S. Scalera, X. Wang, A. Elkrief +23 more
2025Annals of Oncology9 citations Open access
Semantic Scholar
Antitumor activity of vebreltinib and characterization of clinicogenomic features in solid tumors with MET rearrangements.
S. Nakazawa, Federica Pecci, I. Odintsov, Dimitris Gazgalis +45 more
2025Cancer Discovery8 citations
Semantic Scholar
Ancestry-Associated Performance Variability of Open-Source AI Models for EGFR Prediction in Lung Cancer
M. Rakaee, A. H. Nassar, M. Tafavvoghi, Falah Jabar +11 more
2026JAMA Oncology7 citations Open access
Semantic Scholar
MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies.
M. Aldea, S. Lenahan, Marine Locquet, L. Liao +44 more
2026Annals of Oncology7 citations
Semantic Scholar
Microbiome analysis of 940 lung cancers in never-smokers reveals lack of clinically relevant associations
J. McElderry, Tong-Wu Zhang, Wei Zhao, P. Hoang +58 more
2025Nature Communications7 citations Open access
Semantic Scholar
Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8+ and PD-1+ Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors
J. Alessi, James R. Lindsay, Anita Giobbie-Hurder, B. Sharma +43 more
2025JCO Precision Oncology6 citations Open access
Semantic Scholar
MUC4-positive Fibroblastoma: A Distinctive Hyalinized Spindle Cell Neoplasm With Aberrant Nuclear Beta-catenin Expression and Frequent Biallelic Inactivation of APC.
Federico Repetto, I. Odintsov, L. Sholl, J. Hornick +1 more
2025American Journal of Surgical Pathology6 citations
Semantic Scholar
Pan-tumor harmonization of pathologic response assessment for standardized data collection in neoadjuvant trials (PATHdata): results of a Society for Immunotherapy of Cancer multi-institutional reproducibility study
J. S. Deutsch, T. Cottrell, K.-Y. Chen, C. De Andrea +19 more
2026Annals of Oncology5 citations
Semantic Scholar
EGFR-mutant transformed small cell lung cancer harbors intratumoral heterogeneity targetable with MEK inhibitor combination therapy
Atsuko Ogino, Amir Vajdi, Xinmeng Jasmine Mu, N. Mahadevan +28 more
2026JCI Insight5 citations Open access
Semantic Scholar
TTF-1 expression in lung adenocarcinoma: clinicopathologic, genomic, and immunophenotypic correlates and outcomes to immunotherapy-based treatments and KRASG12C inhibitors.
A. Di Federico, L. Hong, A. Elkrief, R. Thummalapalli +44 more
2026Journal of Thoracic Oncology4 citations
Semantic Scholar
Examining the Role of Extrachromosomal DNA in Lung Cancer
A. Khandekar, P. Hoang, J. Luebeck, M. Díaz-Gay +29 more
2025bioRxiv4 citations Open access
Semantic Scholar
A prognostic signature for lung adenocarcinoma in patients who have never smoked
Wei Zhao, Tong-Wu Zhang, X. Hua, P. Hoang +65 more
2025Cancer Discovery4 citations
Semantic Scholar
Presenting features and causes of diagnostic delays: A report from the NUT carcinoma registry
S. A. Walton, Justin J. Kim, Francesco Paoloni, J. Liew +17 more
2025JCO Precision Oncology3 citations
Semantic Scholar
Multi-omics analysis reveals differential benefits of immunotherapy±chemotherapy based on detailed smoking history in advanced non-small cell lung cancer
Xinan Wang, B. Ricciuti, A. Elkrief, J. Alessi +12 more
2025Journal for ImmunoTherapy of Cancer3 citations Open access
Semantic Scholar
1691 A Complementary Role for Immunohistochemistry and NGS for Detection of MTAP Gene Deletion in Patients with Non-Small Cell Lung Cancer
Sanna Ilonen, I. Odintsov, Alice Shaw, L. Sholl
2025Laboratory Investigation3 citations
Semantic Scholar
The Genomic Landscape of NSCLC in Systemic Sclerosis Reveals Frequent TP53 Mutations and a Paucity of Actionable Oncogenes.
I. Odintsov, M. M. Hammer, B. Ricciuti, Federica Pecci +3 more
2025Journal of Thoracic Oncology3 citations
Semantic Scholar
Acquired SMARCA4 alterations: An uncommon contributor to cancer progression in lung adenocarcinomas.
Andréanne Gagné, J. Alessi, B. Ricciuti, G. Lamberti +2 more
2025Lung Cancer3 citations
Semantic Scholar
Clinical Implementation of Matched Tumor/Germline Sequencing Improves Accuracy of Tumor Genomic Profiling and Therapeutic Recommendations.
Danielle K. Manning, G. Ananda, Cheryl Eifert, V. Rojas-Rudilla +27 more
2025Journal of Molecular Diagnostics3 citations Open access
Semantic Scholar
Machine learning assessment of pathologic response in lung cancer resections after neoadjuvant therapy - IASLC MPR Project.
S. Dacic, Daniel Shenker, M. Redman, Laurent Brunner +38 more
2026Journal of Thoracic Oncology2 citations
Semantic Scholar
Clinical Utility of Next-Generation Sequencing in Tumors Diagnosed as Lung Squamous Cell Carcinoma: Real-World Data of Diagnostic and Therapeutic Implications.
I. Odintsov, Stephanie E. Siegmund, Federica Pecci, B. Ricciuti +5 more
2026Modern Pathology2 citations
Semantic Scholar
Efficacy and Safety of Tarlatamab in a Patient With Advanced Delta-Like Ligand 3-Positive Large Cell Neuroendocrine Lung Carcinoma and Untreated Brain Metastases: A Case Report.
E. Gariazzo, Sanna Laaksonen, S. Canty, G. D. De Almeida +9 more
2025JCO Precision Oncology2 citations
Semantic Scholar
Radiological distribution patterns in restrictive chronic lung allograft dysfunction: Impact on survival across all phenotypes
T. Fukuda, Y. Nakamura, Shu-Chi Tseng, Yuki Ko +8 more
2025JHLT open2 citations Open access
Semantic Scholar
233P: Chemo-immunotherapy for borderline resectable and unresectable NSCLC
F. Cappuzzo, L. Landi, E. Garbo, A. Cooper +16 more
2025Journal of Thoracic Oncology2 citations
Semantic Scholar
Molecular and immunohistochemical characterization of ERBB2 activating mutations in low‐grade serous ovarian carcinoma
Alexander J. Neil, Dingani Nkosi, Ju-Yoon Yoon, D. Kolin +1 more
2025Histopathology2 citations
Semantic Scholar
Optimizing treatment pathways with multidisciplinary team discussions in stage II–III non-small cell lung cancer
N. Chudgar, D. Behl, K. Higgins, B. Sepesi +3 more
2026JTO Clinical and Research Reports1 citations Open access
Semantic Scholar
Abstract PS1-10-18: Genomic analysis of ER+/HER2- metastatic invasive lobular carcinoma (ILC) and clinical outcomes comparison with metastatic invasive carcinoma of no special type (NST)
K. Fanucci, S. Challa, Y. Li, G. Nader-Marta +10 more
2026Clinical Cancer Research1 citations
Semantic Scholar
Resection Outcomes According to Pathologic Risk in ≤2 cm Invasive Lung Adenocarcinoma.
Zhi-Zhou Yang, D. Xiong, E. Yuan, Jae M. Cho +11 more
2026Journal of Thoracic and Cardiovascular Surgery1 citations
Semantic Scholar
Real-time margin assessment for video-assisted thoracic surgery: A pilot clinical trial
J. Jagadeesan, Sarah Lobo, A. Lucas, J. Barlow +8 more
2025JTCVS Techniques1 citations Open access
Semantic Scholar
Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with oncogene-driver negative NSCLC who have never smoked.
E. Gariazzo, A. Elkrief, K. Concannon, G. Metro +15 more
2025Journal of Clinical Oncology1 citations
Semantic Scholar
Differential predictive impact of PD-L1 expression on immunotherapy outcomes and immunophenotype in squamous versus non-squamous NSCLC.
Valentina Santo, A. Elkrief, K. Concannon, A. Di Federico +11 more
2025Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Mutational Signature in Cancers Following Solid Organ or Allogeneic Stem Cell Transplantation
I. Odintsov, Stephanie E. Siegmund, N. Mahadevan, A. Church +2 more
2025Modern Pathology1 citations
Semantic Scholar
P1.07.37 Using Tissue and Blood to Find Oncogenic Drivers Upfront in Patients With Lung Cancer Evaluated for Neoadjuvant Therapy-LEADER
J. Lin, J. Lee, R. Ripley, H. Tsukada +33 more
2025Journal of Thoracic Oncology1 citations Open access
Semantic Scholar
Mutational signature analysis of chronic lymphocytic leukemia uncovering genomic patterns and prognostic implications.
A. AlJabban, Roberta S. Azevedo, Katherine Antel, Allison Arnette +12 more
2025American Journal of Clinical Pathology1 citations
Semantic Scholar
Clinicogenomic characterization of inflammatory breast cancer
N. Priedigkeit, Beth Harrison, Robert Shue, M. Hughes +26 more
2025Clinical Cancer Research1 citations Open access
Semantic Scholar
P3.12.63 MTAPloss Is Frequent and Potentially Targetable With PRMT5 Inhibitors in Oncogene-Driven NSCL
M. Aldea, M. Locquet, L. Liao, K. Ngo +19 more
2025Journal of Thoracic Oncology1 citations Open access
Semantic Scholar
A Concordance Study Among 26 NGS Laboratories Participating in the National Cancer Institute-Molecular Analysis for Therapy Choice (NCI-MATCH) Clinical Trial
Linda K Zane, Laura M. Yee, Ting-Chia Chang, J. Sklar +78 more
2025Clinical Cancer Research1 citations
Semantic Scholar
Abstract PR005: KRAS amplification as de novo oncogenic alteration and therapeutic target in human cancers
Mark M. Awad, B. Ricciuti, S. V. Michelina, E. Garbo +31 more
2026Cancer Research0 citations
Semantic Scholar
MO16.06: Margin Benchmark for Adequate Local Control in=2 cm Nodal Negative Invasive Lung Adenocarcinoma Sublobar Resection
Z. Yang, E. Yuan, D. Xiong, J. Cho +11 more
2026Journal of Thoracic Oncology0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Federica Pecci×12
Invite
Federica Pecci — researcher profile on SciRah
B. Ricciuti×11
Invite
B. Ricciuti — researcher profile on SciRah
A. Di Federico×9
Invite
A. Di Federico — researcher profile on SciRah
J. Alessi×8
Invite
J. Alessi — researcher profile on SciRah

×7

Invite

E. Garbo — researcher profile on SciRah

Invite

M. Aldea — researcher profile on SciRah

Invite

M. Awad — researcher profile on SciRah

Invite

E. Gariazzo — researcher profile on SciRah

Invite

J. Chaft — researcher profile on SciRah

Invite

A. Elkrief — researcher profile on SciRah

Invite

B. Ricciuti — researcher profile on SciRah

Valentina Santo×5

Invite

Valentina Santo — researcher profile on SciRah